ArticleCureus2025
Chasing the Dragon Syndrome: A Case of Toxic Leukoencephalopathy and Response to Intravenous Immunoglobulin.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heroin inhalational leukoencephalopathy (HLE), also known as "chasing the dragon" syndrome, is a rare but severe neurological disorder associated with inhaling heroin vapors. It is characterized by progressive white matter damage and distinctive magnetic resonance imaging (MRI) findings, with no definitive treatment and a generally poor prognosis. We report the case of a 43-year-old man with a history of polysubstance abuse who presented with acute altered mental status. Initial investigations revealed aspiration pneumonia and a positive urine drug screen for cocaine and opioids. Magnetic resonance imaging (MRI) of the brain demonstrated diffuse, symmetrical T2-weighted fluid-attenuated inversion recovery (T2/FLAIR) hyperintensities in the white matter, sparing the deep gray nuclei, brainstem, and cerebellum, findings consistent with toxic leukoencephalopathy. Despite treatment with antibiotics, steroids, supportive care, and psychiatric management, his neurological condition deteriorated, requiring intensive care unit (ICU) admission and mechanical ventilation. Administration of intravenous immunoglobulin (IVIG) at a total dose of 2 g/kg over three days resulted in improvement in awareness and motor function. He was eventually discharged to a subacute rehabilitation facility. This case highlights the diagnostic complexity of HLE in the setting of multi-substance use, where imaging findings may overlap with other toxic encephalopathies. The observed clinical improvement following IVIG raises the possibility of a therapeutic role, warranting further investigation. Early recognition of (heroin inhalational leukoencephalopathy) HLE and its imaging findings is essential to initiate supportive interventions and explore emerging therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.